Employers Holdings's 15min chart shows bullish signals with KDJ Golden Cross and Marubozu.
ByAinvest
Wednesday, Sep 17, 2025 2:04 pm ET2min read
ALNY--
This bullish momentum aligns with broader trends of Golden Crosses and bullish Marubozu formations observed in several other stocks, including ASGN and Cushing NextGen. While technical analysis provides valuable insights into potential stock price movements, it is crucial for investors to consider these signals in conjunction with fundamental analysis and broader market conditions [1].
As of July 7, 2025, several notable companies have seen updates to their analyst ratings and price targets, reflecting the evolving opinions of financial experts. Positive Outlook: Alnylam Pharma (ALNY) received a "Buy" rating from Jefferies with a price target of $384.00. Chime Financial (CHYM) was initiated with an "Overweight" rating by multiple firms, including Morgan Stanley and Barclays, with targets ranging from $39.00 to $40.00. CryoPort (CYRX) was rated "Buy" by BTIG Research with a price target of $10.00. Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating. Energy Transfer (ET) was initiated with a "Buy" rating by TD Cowen with a price target of $22.00. Grab (GRAB) was rated "Buy" by Jefferies with a price target of $5.70, indicating a 20.94% upside. Home Depot (HD) was rated "Buy" by TD Cowen with a price target of $470.00. Intuit (INTU) was rated "Buy" by Morgan Stanley with a price target of $900.00. JPMorgan Chase & Co. (JPM) had a $298.00 target set by Evercore ISI with an "Outperform" rating. Kinder Morgan (KMI) was initiated with a "Buy" rating by TD Cowen. Lam Research (LRCX) had its "Buy" rating reiterated by Citigroup. MACOM Technology Solutions (MTSI) had its target raised from $136.00 to $154.00 by Truist Financial, maintaining a "Buy" rating. Monopar Therapeutics (MNPR) was initiated with an "Overweight" rating by Cantor Fitzgerald and a target of $74.00. Norwegian Cruise Line (NCLH) received a "Buy" rating from Jefferies with a price target of $29.00. Oracle (ORCL) received a "Buy" rating from UBS with a $250.00 target. Oportun Financial (OPRT) was rated "Buy" at B. Riley Financial with an $11.00 price target. Ovintiv (OVV) was rated "Buy" at Barclays Capital with a price target of $55.00. Phibro Animal Health (PAHC) was upgraded at JPMorgan Chase from Neutral to Overweight, with the price target raised from $25.00 to $35.00. Progressive (PGR) was downgraded by Morgan Stanley from Overweight to Equal Weight, with a price target of $290.00. Pulse Biosciences (PLSE) was initiated by Oppenheimer with an "Outperform" rating and a $22.00 price target. PTC (PTC) had its Overweight rating reiterated by KeyCorp Bank. Rockwell Automation (ROK) was initiated by CICC Research with a "Buy" rating and a price target of $320.00 FBIO.O Surges 30.6% on KDJ Golden Cross Amid Sector Divergence .
Investors should closely monitor the ongoing developments in Employers Holdings and consider the broader market conditions when making investment decisions. Technical analysis, combined with fundamental analysis, can provide a more comprehensive view of potential stock price movements.
ASGN--
BAC--
BCS--
C--
Employers Holdings's 15-minute chart has recently triggered a Golden Cross on the KDJ indicator and a bullish Marubozu at 09/17/2025 14:00. This suggests a shift in momentum towards an upward trend, with potential for further growth. The control of the market is currently with buyers, and the bullish momentum is likely to continue.
Employers Holdings' 15-minute chart has recently triggered a Golden Cross on the KDJ indicator and a bullish Marubozu at 09/17/2025 14:00. This technical shift suggests a potential shift in momentum towards an upward trend, with buyers currently in control of the market. The Golden Cross, a crossover of the K and D lines in the KDJ indicator, typically signals a change from bearish to bullish trends. This strong technical signal often aligns with a continuation of the current trend, indicating that the price is likely to move higher. The bullish Marubozu candlestick pattern, characterized by a long body with no shadows above or below, further confirms strong buying pressure [1].This bullish momentum aligns with broader trends of Golden Crosses and bullish Marubozu formations observed in several other stocks, including ASGN and Cushing NextGen. While technical analysis provides valuable insights into potential stock price movements, it is crucial for investors to consider these signals in conjunction with fundamental analysis and broader market conditions [1].
As of July 7, 2025, several notable companies have seen updates to their analyst ratings and price targets, reflecting the evolving opinions of financial experts. Positive Outlook: Alnylam Pharma (ALNY) received a "Buy" rating from Jefferies with a price target of $384.00. Chime Financial (CHYM) was initiated with an "Overweight" rating by multiple firms, including Morgan Stanley and Barclays, with targets ranging from $39.00 to $40.00. CryoPort (CYRX) was rated "Buy" by BTIG Research with a price target of $10.00. Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating. Energy Transfer (ET) was initiated with a "Buy" rating by TD Cowen with a price target of $22.00. Grab (GRAB) was rated "Buy" by Jefferies with a price target of $5.70, indicating a 20.94% upside. Home Depot (HD) was rated "Buy" by TD Cowen with a price target of $470.00. Intuit (INTU) was rated "Buy" by Morgan Stanley with a price target of $900.00. JPMorgan Chase & Co. (JPM) had a $298.00 target set by Evercore ISI with an "Outperform" rating. Kinder Morgan (KMI) was initiated with a "Buy" rating by TD Cowen. Lam Research (LRCX) had its "Buy" rating reiterated by Citigroup. MACOM Technology Solutions (MTSI) had its target raised from $136.00 to $154.00 by Truist Financial, maintaining a "Buy" rating. Monopar Therapeutics (MNPR) was initiated with an "Overweight" rating by Cantor Fitzgerald and a target of $74.00. Norwegian Cruise Line (NCLH) received a "Buy" rating from Jefferies with a price target of $29.00. Oracle (ORCL) received a "Buy" rating from UBS with a $250.00 target. Oportun Financial (OPRT) was rated "Buy" at B. Riley Financial with an $11.00 price target. Ovintiv (OVV) was rated "Buy" at Barclays Capital with a price target of $55.00. Phibro Animal Health (PAHC) was upgraded at JPMorgan Chase from Neutral to Overweight, with the price target raised from $25.00 to $35.00. Progressive (PGR) was downgraded by Morgan Stanley from Overweight to Equal Weight, with a price target of $290.00. Pulse Biosciences (PLSE) was initiated by Oppenheimer with an "Outperform" rating and a $22.00 price target. PTC (PTC) had its Overweight rating reiterated by KeyCorp Bank. Rockwell Automation (ROK) was initiated by CICC Research with a "Buy" rating and a price target of $320.00 FBIO.O Surges 30.6% on KDJ Golden Cross Amid Sector Divergence .
Investors should closely monitor the ongoing developments in Employers Holdings and consider the broader market conditions when making investment decisions. Technical analysis, combined with fundamental analysis, can provide a more comprehensive view of potential stock price movements.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet